Comparison of monotherapy with valproate and other antiepileptic drugs in the treatment of seizure disorders.
Comparative data strongly suggest that valproate is the drug of choice for patients with primary and secondarily generalized epilepsies and that it is as effective as other antiepileptic drugs in the treatment of less clearly defined or partial epilepsies beginning in adult life. In simple absence epilepsy, several studies found no significant difference in efficacy between valproate and ethosuximide. In all primary generalized epilepsies, valproate has in many studies produced an excellent response, with one comparative study showing that valproate was as effective as phenytoin. Infantile spasms responded as well to valproate as to adrenocorticotropic hormone in several studies, while valproate produced fewer side effects. More long-term studies designed to compare the efficacy of monotherapy with valproate with that of other antiepileptic drugs are needed, and several are underway in both Europe and the United States.
Chadwick
D
D
Walton Hospital, Liverpool, England.
D000927:Anticonvulsants / Q000627:therapeutic use*; D004831:Epilepsies, Myoclonic / Q000188:drug therapy; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D014635:Valproic Acid / Q000008:administration & dosage* / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid